Cite
HARVARD Citation
Curto‐Barredo, L. et al. (2018). Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria. British journal of dermatology. pp. 210-212. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Curto‐Barredo, L. et al. (2018). Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria. British journal of dermatology. pp. 210-212. [Online].